Compound Summary
Compound Information
L-162,313
Compound Name: | L-162,313 |
Compound CID: | 6603900 |
Synonyms: | L-162,313 151488-11-8 L-162313 L 162313 CHEMBL288174 More... |
Iupac Name: | butyl N-[3-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate |
InChI: | InChI=1S/C30H38N4O4S2/c1-7-9-14-38-30(35)33-40(36,37)29-25(17-24(39-29)15-19(3)4)23-12-10-22(11-13-23)18-34-26(8-2)32-27-20(5)16-21(6)31-28(27)34/h10-13,16-17,19H,7-9,14-15,18H2,1-6H3,(H,33,35) |
InChIKey: | RINPELQWLUGERM-UHFFFAOYSA-N |
Canonical Smiles: | CCCCOC(=O)NS(=O)(=O)C1=C(C=C(S1)CC(C)C)C2=CC=C(C=C2)CN3C(=NC4=C3N=C(C=C4C)C)CC |
Isomeric Smiles: | CCCCOC(=O)NS(=O)(=O)C1=C(C=C(S1)CC(C)C)C2=CC=C(C=C2)CN3C(=NC4=C3N=C(C=C4C)C)CC |
Molecular Weight: | 582.8 |
Molecular Formula: | C30H38N4O4S2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
L-162,313
Molecular Weight: | 582.8 |
Molecular Formula: | C30H38N4O4S2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 7 |
Rotatable Bond Count: | 12 |
Heavy Atom Count: | 40 |
Complexity: | 921 |
Synonyms
L-162,313
| L-162,313 | L-162,313 |
|---|---|
L-162,313 |
151488-11-8 |
L-162313 |
L 162313 |
CHEMBL288174 |
butyl N-3-4-(2-ethyl-5,7-dimethylimidazo4,5-bpyridin-3-yl)methylphenyl-5-(2-methylpropyl)thiophen-2-ylsulfonylcarbamate |
butyl N-3-4-(2-ethyl-5,7-dimethylimidazo5,4-bpyridin-3-yl)methylphenyl-5-(2-methylpropyl)thiophen-2-ylsulfonylcarbamate |
5,7-Dimethyl-2-ethyl-3-4-2(N-butyloxycarbonylsulfonamido)-5-isobutyl-3-thienylphenylmethylImidazo4,5,6pyridine |
butyl (3-(4-((2-ethyl-5,7-dimethyl-3H-imidazo4,5-bpyridin-3-yl)methyl)phenyl)-5-isobutylthiophen-2-yl)sulfonylcarbamate |
butyl 3-(4-((2-ethyl-5,7-dimethyl-3H-imidazo4,5-bpyridin-3-yl)methyl)phenyl)-5-isobutylthiophen-2-ylsulfonylcarbamate |
Lopac-L-1415 |
Lopac0_000697 |
MLS002153426 |
GTPL3936 |
L 162,313 |
SCHEMBL9132197 |
DTXSID30934268 |
C30H38N4O4S2 |
HMS3262K15 |
ZINC3918293 |
Tox21_500697 |
BDBM50049189 |
MFCD00915204 |
CCG-204782 |
LP00697 |
SDCCGSBI-0050675.P002 |
NCGC00015596-01 |
NCGC00015596-02 |
NCGC00015596-03 |
NCGC00015596-04 |
NCGC00094051-01 |
NCGC00094051-02 |
NCGC00261382-01 |
5,7-Dimethyl-2-ethyl-3-4-2-(n-butyloxycarbonylsulfonamido)-5-isobutyl-3-thienylphenylmethylimidazo-4,5-b-pyridine |
SMR001230801 |
L-162,313, >=95%, solid |
EU-0100697 |
FT-0732122 |
Z3214 |
L 1415 |
SR-01000076212 |
SR-01000076212-1 |
(5,7-dimethyl-2-ethyl-3-4-2(n-butyloxycarbonylsulfonamido)-5-isobutyl-3-thienylphenylmethylimidazo4,5,6pyridine |
3-4-(2-Ethyl-57-dimethyl-imidazo45-bpyridin-3-ylmethyl)-phenyl-5-isobutyl-thiophene-2-sulfonic acid butyloxycarbonylamide(L-162313) |
5,7-Dimethyl-2-ethyl-3-4-2??(n-butyloxycarbonylsulfonamido)-5-isobutyl-3-thienylphenylmethylimidazo??4,5-b??pyridine |
Experimental Data
L-162,313
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 13 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
L-162,313
Statistics Data
L-162,313
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 13 | 1 | 1 |
Statistics Data Visualization
L-162,313
